Global Obstructive Hydrocephalus Market, By Types (Acute and Chronic), Diagnosis (Medical history, MRI, CT Scan, Physical and Neurological Examination), Treatment (Ventriculoperitoneal Shunt, Third Ventriculostomy), Causes (Head Trauma, Stroke, Bleeding, Central Nervous System Tumors, Surgery Complications), Symptoms (Irritability, Headache, Nausea, Cognitive Changes, Seizures, Vision Problems, Personality Changes), End-Users (Clinics, Hospitals, Diagnostic centres, Home healthcare, others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.
Obstructive Hydrocephalus Market Analysis and Size
Obstructive hydrocephalus is also called non-communicable hydrocephalus. It is a condition in which fluid build-up in brain. Acute obstructive hydrocephalus causes high intracranial pressure that can cause death, and chronic hydrocephalus don’t have serious symptoms.Rise in the prevalence of brain injury, ongoing development and commercialisation that will increase the demand of shunts, proper policies by government and healthcare sectors, and increasing neurovascular disease are the driving factors for the global obstructive hydrocephalus market growth.
Data Bridge Market Research analyses that the global obstructive hydrocephalus market which was USD 2,733.72 million in 2022, is expected to reach USD 5,572.20 million by 2030, and is expected to undergo a CAGR of 7.3% during the forecast period 2023-2030. This indicates that the market value. “Head Trauma” dominates the causes segment of the global obstructive hydrocephalus market owing to Rise in the prevalence of brain injury. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Obstructive Hydrocephalus Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2014-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Types (Acute and Chronic), Diagnosis (Medical history, MRI, CT scan, Physical and neurological examination), Treatment (Ventriculoperitoneal shunt, third ventriculostomy), Causes (Head trauma, Stroke, bleeding, central nervous system tumors, surgery complications), Symptoms (Irritability, headache, nausea, cognitive changes, seizures, vision problems, personality changes), End-Users (Clinics, Hospitals, Diagnostic centres, Home healthcare, others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
|
|
Countries Covered
|
U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
|
|
Market Players Covered
|
DePuy Synthes (U.S.), Boston Neuropsychological services (U.S.), Medtronic (Ireland), Integra Life Sciences (U.S.), Spiegelberg GmbH & Co. KG(Germany), Sophysa (France), Terumo Corporation (Japan), Natus Medical Incorporated (U.S.), Johnson & Johnson Private limited (U.S.), B. Braun Melsungen AG (Germany), Christoph Miethke GmbH & Co. KG (Deutschland), and TKB Corporation (Japan)
|
|
Market Opportunities
|
|
Market Definition
Obstructive hydrocephalus is also called non-communicable hydrocephalus. It is a condition in which fluid build-up in brain. Acute obstructive hydrocephalus causes high intracranial pressure that can cause death, and chronic hydrocephalus don’t have serious symptoms.
Global Obstructive Hydrocephalus Market Dynamics
Drivers
- Rise in Number of Research and Development Activities
Rise in number of research and development activities, rise in awareness about Ventriculoperitoneal shunt, third ventriculostomy are expected to provide beneficial opportunities for the global obstructive hydrocephalus market.
- Rise in the Prevalence of Brain Injury
Rise in the prevalence of brain injury, ongoing development and commercialisation that will increase the demand of shunts, proper policies by government and healthcare sectors, and increasing neurovascular disease are the driving factors for the global obstructive hydrocephalus market growth.
Opportunity
- Changing Consumer Lifestyles and Preferences
Rise in number of research and development activities, rise in awareness about Ventriculoperitoneal shunt, third ventriculostomy are expected to provide beneficial opportunities for the global obstructive hydrocephalus market
Restraint/Challenge
- High Excise Duties
Higher costs for treatment and worsening of symptoms can act as a restraint, and will further challenge the global obstructive hydrocephalus market
This global obstructive hydrocephalus market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global obstructive hydrocephalus market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In June 2021, Medtronic has announced the U.S. Food and Drug Administration (FDA) approval and the first U.S. implants of the SenSight Directional Lead System used for Deep Brain Stimulation (DBS) therapy. It will enhance their product sales in the neurological field
Global Obstructive Hydrocephalus Market Scope
Global obstructive hydrocephalus market is segmented on the basis of types, diagnosis, treatment, causes, symptoms, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Types
- Acute
- Chronic
Diagnosis
- Medical History
- MRI
- CT Scan
- Physical
- Neurological Examination
Treatment
- Ventriculoperitoneal Shunt
- Third Ventriculostomy
Causes
- Head Trauma
- Stroke
- Bleeding
- Central Nervous System Tumors
- Surgery Complications
Symptoms
- Irritability
- Headache
- Nausea
- Cognitive Changes
- Seizures
- Vision Problems
- Personality Changes
End-Users
- Clinics
- Hospitals
- Diagnostic centres
- Home healthcare
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Obstructive Hydrocephalus Market Analysis/Insights
Global obstructive hydrocephalus market is analyzed and market size information is provided by types, diagnosis, treatment, causes, symptoms, end-users, and distribution channel as referenced above.
The countries covered in the global obstructive hydrocephalus market reports are U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the global obstructive hydrocephalus market due to the existence of huge number of players, well-developed healthcare sector, and increase in the government support for research & development in this region.
Asia Pacific is expected to grow during the forecast period 2023-2030, due to the increased occurrence of obstructive hydrocephalus combined with increasing investment of shunt manufacturers.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Obstructive Hydrocephalus Market Share Analysis
Global obstructive hydrocephalus market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global obstructive hydrocephalus market.
Some of the major players operating in the global obstructive hydrocephalus market are:
- DePuy Synthes (U.S.)
- Boston Neuropsychological services (U.S.)
- Medtronic (Ireland)
- Integra Life Sciences (U.S.)
- Spiegelberg GmbH & Co. KG(Germany)
- Sophysa (France)
- Terumo Corporation (Japan)
- Natus Medical Incorporated (U.S.)
- Johnson & Johnson Private limited (U.S.)
- B. Braun Melsungen AG (Germany)
- Christoph Miethke GmbH & Co. KG (Deutschland)
- TKB Corporation (Japan)
SKU-